, Tracking Stock Market Picks
Enter Symbol:
Meridian Bioscience Inc. (VIVO) [hlAlert]

Long-term Buy
down 30.17 %

Meridian Bioscience Inc. (VIVO) rated Long-term Buy by Hilliard Lyons

Posted on: Monday,  Jul 21, 2008  9:25 AM ET by Hilliard Lyons

Hilliard Lyons rated Long-term Buy Meridian Bioscience Inc. (NASDAQ: VIVO) on 07/21/2008, when the stock price was $26.81.
Since then, Meridian Bioscience Inc. has lost 30.18% as of 01/20/2016's recent price of $18.72.
If you would have followed this Hilliard Lyons's recommendation on VIVO, you would have lost 30.17% of your investment in 2739 days.

Meridian Bioscience, Inc. is a fully-integrated life science company. The Company?s principal businesses are the development, manufacture, sale and distribution of diagnostic test kits, primarily for certain respiratory, gastrointestinal, viral and parasitic infectious diseases; the manufacture and distribution of bulk antigens, antibodies, and reagents used by researchers and other diagnostic manufacturers, and the contract development and manufacture of proteins and other biologicals for use by biopharmaceutical and biotechnology companies engaged in research for new drugs and vaccines. It has three business segments: US Diagnostics, European Diagnostics and Life Science. The Company?s primary source of domestic and international revenues is core diagnostic products, which represented 83% of consolidated net sales during the fiscal year ended September 30, 2008 (fiscal 2008).

The process of building, preserving and passing along your wealth to the next generation requires a deep understanding of complex trends in business, technology, governmental policy and the economy. More importantly, it requires an awareness of how these trends can impact your investments and ultimately your life goals.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/21/2008 9:25 AM Buy
as of 12/24/2008
1 Week up  5.24 %
1 Month down  -6.72 %
3 Months down  -24.98 %
1 YTD down  -36.23 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy